Running nose since morning 57 year old feamle Medication?
| Drug | Dose | Notes |
|---|---|---|
| Cetirizine (2nd-gen antihistamine) | 10 mg once daily | Preferred in older adults - less sedating |
| Loratadine (2nd-gen antihistamine) | 10 mg once daily | Non-sedating, safe in elderly |
| Fexofenadine | 180 mg once daily | Least sedating option |
| Intranasal antihistamine (azelastine) | 2 sprays/nostril BID | Rapid local effect |
Avoid 1st-generation antihistamines (chlorphenamine, diphenhydramine) in a 57-year-old woman - they cause sedation, confusion, urinary retention, and fall risk in older adults.
| Drug | Dose | Notes |
|---|---|---|
| Intranasal corticosteroid (fluticasone, budesonide, mometasone) | 1-2 sprays/nostril once daily | Best overall for allergic rhinitis; takes 1-2 days to work |
| Oxymetazoline nasal spray | 2-3 sprays/nostril BID | Use max 3 days only - rebound congestion risk |
| Pseudoephedrine (oral decongestant) | 30-60 mg every 4-6h | Use with caution - raises BP; check her hypertension/cardiac history |
| Drug | Notes |
|---|---|
| Intranasal ipratropium bromide | Directly reduces rhinorrhea; useful add-on if antihistamines alone are insufficient |
| Concern | Recommendation |
|---|---|
| Hypertension (common at this age) | Avoid pseudoephedrine or use only short-term with BP monitoring |
| Sedation/falls risk | Avoid 1st-gen antihistamines (chlorphenamine, promethazine) |
| Osteoporosis | Prolonged intranasal corticosteroids are generally safe - systemic absorption is minimal |
| Drug interactions | Check for ACE inhibitors (can cause drug-induced rhinitis itself) |

Important clinical note: If symptoms persist beyond 7-10 days, worsen, or are accompanied by fever, facial pain, or purulent discharge, she should be evaluated for sinusitis or bacterial superinfection. If she is on an ACE inhibitor (e.g., enalapril, ramipril), drug-induced rhinitis should be considered as a cause.
Flupacet?
Flupacet drug composition uses rhinitis cold
Flupacet tablet brand India composition paracetamol
| Component | Dose | Role |
|---|---|---|
| Flupirtine | 100 mg | Non-opioid centrally acting analgesic (NMDA antagonist / potassium channel opener) |
| Paracetamol | 325 mg | Antipyretic + mild analgesic |
Flupirtine was withdrawn from the European Union market in 2018 due to risk of serious liver injury (hepatotoxicity). It remains available in India under restricted use. It should not be used casually or without clear indication.